Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

3.7%

1 terminated out of 27 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

19%

5 trials in Phase 3/4

Results Transparency

40%

6 of 15 completed with results

Key Signals

6 with results94% success

Data Visualizations

Phase Distribution

20Total
Not Applicable (12)
P 1 (2)
P 2 (1)
P 4 (5)

Trial Status

Completed15
Unknown7
Recruiting3
Terminated1
Not Yet Recruiting1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT06053307Not ApplicableCompletedPrimary

Treating Psychosocial Distress in Glaucoma

NCT03675412Not ApplicableRecruitingPrimary

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

NCT04007276Phase 4Not Yet Recruiting

The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients

NCT04899063Not ApplicableCompletedPrimary

Excimer Laser Trabeculostomy Glaucoma Treatment Study

NCT05999006Not ApplicableRecruitingPrimary

Safety and Feasibility of the ELIOS System in POAG Patients

NCT05370287Not ApplicableRecruitingPrimary

Adaptive Optics Retinal Imaging

NCT04149899Phase 1CompletedPrimary

Safety and IOP-Lowering Effects of WB007

NCT05964634Unknown

Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia

NCT05181046Not ApplicableCompleted

Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients

NCT05673954UnknownPrimary

Glaucoma Assessment Via Reading Ability

NCT04465864Phase 4CompletedPrimary

Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert

NCT05474716Phase 4CompletedPrimary

The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA

NCT03151577Not ApplicableUnknown

Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent

NCT02858284Not ApplicableTerminatedPrimary

Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension

NCT04737928Not ApplicableCompletedPrimary

Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)

NCT02796560Phase 4CompletedPrimary

Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT04321122Not ApplicableUnknown

UCP (Ultrasound Cyclo Plasty) in the Treatment of Chinese Patients With Primary Open-angle Glaucoma

NCT01999348CompletedPrimary

A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting

NCT01853085CompletedPrimary

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons

NCT03800589Not ApplicableCompleted

Assessment of Effectiveness Ex-Press Surgery Modification

Scroll to load more

Research Network

Activity Timeline